Emerald Mutual Fund Advisers Trust’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-126,266	Closed	-$8.39M	–	239
2021 Q3	$8.39M	Sell	126,266 -1,079	-0.8%	-$76.9K	0.29%	99
2021 Q2	$9.94M	Sell	127,345 -58,320	-31%	-$4.31M	0.33%	105
2021 Q1	$17.6M	Sell	185,665 -150,508	-45%	-$17.9M	0.58%	80
2020 Q4	$41M	Buy	336,173 +53,733	+19%	+$5.89M	1.43%	12
2020 Q3	$24.7M	Buy	282,440 +86,937	+44%	+$6.06M	1.09%	32
2020 Q2	$12.6M	Buy	195,503 +147,420	+307%	+$8.5M	0.6%	63
2020 Q1	$2.15M	Buy	+48,083	New	+$2.55M	0.13%	130

Other funds holding TPTX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TPTX Position: Q4 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 126,266 shares — an estimated $8.39M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TPTX in Q1 2020 and held it in 7 quarters. The position peaked at $41M in Q4 2020. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

Emerald Mutual Fund Advisers Trust reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 126,266 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $8.39M.
Emerald Mutual Fund Advisers Trust first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Emerald Mutual Fund Advisers Trust's Turning Point Therapeutics, Inc. Common Stock position peaked at $41M in Q4 2020.
172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2021, filed 2 Feb 2022.